Episode Details

Back to Episodes
Glatiramer Acetate (Copaxone, Brabio) for relapsing remitting multiple sclerosis

Glatiramer Acetate (Copaxone, Brabio) for relapsing remitting multiple sclerosis

Season 1 Episode 65 Published 2 years, 2 months ago
Description

Glatiramer Acetate, brand names Copaxone and Brabio, belongs to the oldest immunotherapies for relapsing remitting multiple sclerosis.

You can find the written version of this episode on my blog: https://ms-perspektive.com/065-glatiramer-acetate

This time I am presenting glatiramer acetate, which is known as Copaxone, Brabio or other tradenames and is one of the approved disease-modifying drugs for relapsing forms of MS. It was one of the first drugs to be approved as a preventive therapy for MS patients and was an accidental discovery. Originally intended to induce MS in mice for research purposes, it was suddenly discovered to have a protective effect. Like the fumarates already presented, it has a more broad-based mechanism of action. I will try to give a good overview below without going into absolute depth. And as always, please seek specific advice from MS specialists who know your individual situation, wishes, fears and overall state of health.

"},"minimize_box":"yes","minimized_on":"tablet","hierarchical_view":"yes","min_height":{"unit":"px","size":"","sizes":[]},"min_height_tablet":{"unit":"px","size":"","sizes":[]},"min_height_mobile":{"unit":"px","size":"","sizes":[]}}" data-widget_type="table-of-contents.default"> Table of Contents Sources

I used the following sources to create the content:

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us